TrialAnnals of hematology2025

Gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia: a regional analysis of COMMODORE in China, South-East Asia, and Russia.

Bin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.